vs
Side-by-side financial comparison of Ladder Capital Corp (LADR) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Ladder Capital Corp is the larger business by last-quarter revenue ($22.3M vs $12.6M, roughly 1.8× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 71.0%, a 179.6% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs -18.0%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -22.5%).
Ladder Capital Corp is a leading commercial real estate finance firm operating primarily across the United States. It originates and manages a diversified portfolio of senior secured commercial mortgage loans, mezzanine debt, commercial mortgage-backed securities, and direct real estate assets, serving property owners, operators and developers across major market segments.
LADR vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.3M | $12.6M |
| Net Profit | $15.9M | $31.5M |
| Gross Margin | — | — |
| Operating Margin | 69.5% | — |
| Net Margin | 71.0% | 250.7% |
| Revenue YoY | -18.0% | 24080.8% |
| Net Profit YoY | -49.4% | 250.9% |
| EPS (diluted) | $0.13 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.3M | $12.6M | ||
| Q3 25 | $27.8M | $0 | ||
| Q2 25 | $21.5M | $0 | ||
| Q1 25 | $20.3M | $12.0K | ||
| Q4 24 | $27.2M | $52.0K | ||
| Q3 24 | $38.4M | $65.0K | ||
| Q2 24 | $34.3M | $114.0K | ||
| Q1 24 | $37.1M | $140.0K |
| Q4 25 | $15.9M | $31.5M | ||
| Q3 25 | $19.2M | $-7.4M | ||
| Q2 25 | $17.1M | $-1.7M | ||
| Q1 25 | $11.6M | $-13.9M | ||
| Q4 24 | $31.3M | — | ||
| Q3 24 | $27.6M | $-17.1M | ||
| Q2 24 | $32.1M | $-17.9M | ||
| Q1 24 | $16.4M | $-12.7M |
| Q4 25 | 69.5% | — | ||
| Q3 25 | 72.4% | — | ||
| Q2 25 | 96.7% | — | ||
| Q1 25 | 52.7% | -122758.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | 74.1% | -28604.6% | ||
| Q2 24 | 90.4% | -16720.2% | ||
| Q1 24 | 49.4% | -9987.1% |
| Q4 25 | 71.0% | 250.7% | ||
| Q3 25 | 69.0% | — | ||
| Q2 25 | 79.5% | — | ||
| Q1 25 | 56.8% | -115550.0% | ||
| Q4 24 | 115.1% | — | ||
| Q3 24 | 71.7% | -26380.0% | ||
| Q2 24 | 93.6% | -15668.4% | ||
| Q1 24 | 44.2% | -9049.3% |
| Q4 25 | $0.13 | $0.56 | ||
| Q3 25 | $0.15 | $-0.13 | ||
| Q2 25 | $0.14 | $-0.03 | ||
| Q1 25 | $0.09 | $-0.25 | ||
| Q4 24 | $0.25 | — | ||
| Q3 24 | $0.22 | $-0.32 | ||
| Q2 24 | $0.26 | $-0.33 | ||
| Q1 24 | $0.13 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $38.0M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.5B | $59.0M |
| Total Assets | $5.2B | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.0M | $40.3M | ||
| Q3 25 | $49.4M | $48.6M | ||
| Q2 25 | $134.9M | $31.2M | ||
| Q1 25 | $479.8M | $48.9M | ||
| Q4 24 | $1.3B | $52.9M | ||
| Q3 24 | $1.6B | $76.3M | ||
| Q2 24 | $1.2B | $63.5M | ||
| Q1 24 | $1.2B | $82.3M |
| Q4 25 | $1.5B | $59.0M | ||
| Q3 25 | $1.5B | $26.5M | ||
| Q2 25 | $1.5B | $32.8M | ||
| Q1 25 | $1.5B | $33.8M | ||
| Q4 24 | $1.5B | $46.1M | ||
| Q3 24 | $1.5B | $65.5M | ||
| Q2 24 | $1.5B | $80.5M | ||
| Q1 24 | $1.5B | $96.2M |
| Q4 25 | $5.2B | $68.9M | ||
| Q3 25 | $4.7B | $54.2M | ||
| Q2 25 | $4.5B | $62.1M | ||
| Q1 25 | $4.5B | $77.7M | ||
| Q4 24 | $4.8B | $110.5M | ||
| Q3 24 | $4.8B | $135.2M | ||
| Q2 24 | $4.8B | $149.9M | ||
| Q1 24 | $5.3B | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $87.0M | $-8.4M |
| Free Cash FlowOCF − Capex | $78.7M | — |
| FCF MarginFCF / Revenue | 352.4% | — |
| Capex IntensityCapex / Revenue | 37.4% | — |
| Cash ConversionOCF / Net Profit | 5.49× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $118.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.0M | $-8.4M | ||
| Q3 25 | $26.3M | $17.4M | ||
| Q2 25 | $44.0M | $-17.7M | ||
| Q1 25 | $-28.7M | $-4.0M | ||
| Q4 24 | $133.9M | $-23.4M | ||
| Q3 24 | $169.0M | $12.8M | ||
| Q2 24 | $45.4M | $-18.7M | ||
| Q1 24 | $-20.4M | $5.9M |
| Q4 25 | $78.7M | — | ||
| Q3 25 | $25.9M | — | ||
| Q2 25 | $43.4M | — | ||
| Q1 25 | $-29.6M | — | ||
| Q4 24 | $127.4M | — | ||
| Q3 24 | $166.0M | — | ||
| Q2 24 | $44.9M | — | ||
| Q1 24 | $-21.7M | — |
| Q4 25 | 352.4% | — | ||
| Q3 25 | 93.1% | — | ||
| Q2 25 | 201.6% | — | ||
| Q1 25 | -145.6% | — | ||
| Q4 24 | 468.2% | — | ||
| Q3 24 | 432.1% | — | ||
| Q2 24 | 131.0% | — | ||
| Q1 24 | -58.6% | — |
| Q4 25 | 37.4% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 4.3% | — | ||
| Q4 24 | 23.9% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 3.7% | — |
| Q4 25 | 5.49× | -0.26× | ||
| Q3 25 | 1.37× | — | ||
| Q2 25 | 2.57× | — | ||
| Q1 25 | -2.49× | — | ||
| Q4 24 | 4.27× | — | ||
| Q3 24 | 6.13× | — | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | -1.24× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
